{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:13:27Z","timestamp":1790342007300,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T00:00:00Z","timestamp":1110240000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The World Health Organization Classification of Lymphoid Neoplasms identifies Burkitt's lymphoma\/leukaemia (BL) as a single entity, characterized by unique clinical and genetic features that require specific high intensity chemotherapy regimens. Although remarkable successes in the treatment of the disease have been observed, when compared with paediatric patients, adults are less likely to reach stable complete remission. We investigated 32 BL cases, composed in equal part by adults and children that were treated with the French LMB regimen, for factors that may be implicated in chemoresistance. Immunohistochemical detection of procaspase\u20108, caspase\u20103a, survivin, p53, CD95, c\u2010Flip and Phospho\u2010RelA (Ser536) was investigated on paraffin\u2010embedded tissues. The expression of c\u2010Flip was found highly related to a poor prognosis, mostly characterized by adults with a chemoresistant disease, resulting in a high death rate within the first year of diagnosis. The 2\u2010year overall survival with c\u2010Flip expression was 24% compared with 93% in the absence of this marker (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b704). All c\u2010Flip\u2010positive BL cases presented a nuclear Phospho\u2010RelA (Ser536) localization, suggesting the presence of an active nuclear factor (NF)\u2010<jats:italic>\u03ba<\/jats:italic>B transcription pathway. These findings show that c\u2010Flip could be a reliable prognostic factor in BL, suggesting new therapeutic approaches that target the NF\u2010<jats:italic>\u03ba<\/jats:italic>B pathway.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05378.x","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T13:03:16Z","timestamp":1110286996000},"page":"767-773","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["c\u2010Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome"],"prefix":"10.1111","volume":"128","author":[{"given":"Marie\u2010Blanche","family":"Valnet\u2010Rabier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Challier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Thiebault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Angonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Margueritte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Mougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Kantelip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deconinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Yves","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,8]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00558-1"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2034995100"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0405"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-003-0474-8"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.7.1025"},{"key":"e_1_2_12_7_1","first-page":"7133","article-title":"Chemotherapy triggers apoptosis in a caspase\u20108\u2010dependent and mitochondria\u2010controlled manner in the non\u2010small cell lung cancer cell line NCI\u2010H460","volume":"60","author":"Ferreira C.G.","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204342"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204141"},{"key":"e_1_2_12_10_1","first-page":"406","article-title":"Classification of non\u2010Hodgkin's lymphomas","volume":"2","author":"Gerard\u2010Marchand R.H.I.","year":"1974","journal-title":"Lancet"},{"key":"e_1_2_12_11_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.139.1.313","article-title":"Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)\u2010like phenotype","volume":"139","author":"Gregory C.D.","year":"1987","journal-title":"Journal of Immunology"},{"key":"e_1_2_12_12_1","first-page":"696","article-title":"Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas\u2010induced apoptosis","volume":"59","author":"Gutierrez M.I.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03643.x"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/35037710"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201770"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401954"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/40657"},{"key":"e_1_2_12_19_1","volume-title":"World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2800"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2000.4838"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316624"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-81092-3"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830210819"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.315"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.10.2794"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.16.5299-5305.2001"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1174"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.4.812"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.8.F21"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.3.1541"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401902"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.5.1727.417k03_1727_1737"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/386517a0"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.9.3053"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1378"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.2.601"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05378.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05378.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:21:54Z","timestamp":1697379714000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05378.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05378.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05378.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2005-03-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}